L, C., G, A., P, O., C, F., A, F., LC, M., . . . G, B. (2022). A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients. NPJ breast cancer, 8(1), 33. https://doi.org/10.1038/s41523-022-00400-6
Chicago Style (17th ed.) CitationL, Coltelli, et al. "A Pharmacogenetic Interaction Analysis of Bevacizumab with Paclitaxel in Advanced Breast Cancer Patients." NPJ Breast Cancer 8, no. 1 (2022): 33. https://doi.org/10.1038/s41523-022-00400-6.
MLA (9th ed.) CitationL, Coltelli, et al. "A Pharmacogenetic Interaction Analysis of Bevacizumab with Paclitaxel in Advanced Breast Cancer Patients." NPJ Breast Cancer, vol. 8, no. 1, 2022, p. 33, https://doi.org/10.1038/s41523-022-00400-6.
Warning: These citations may not always be 100% accurate.